Ferric Carboxymaltose In The Treatment Of Heart Failure And In The Treatment Of Congestion In Heart Failure
AssigneeVifor (International) AG
InventorsClaudio Sergio Mori, Darlington Obinnaya Okonko
Life of this patent
Estimating the term…
Abstract
The invention relates to intravenously administered ferric carboxymaltose for the use as a diuretic medicament, in particular for the treatment of congestion, or of congestion associated with impaired function of the heart and/or associated with deterioration of the function of the heart in a patient suffering from heart failure with iron deficiency or in a patient being iron deficient and at risk of developing heart failure.
Claims21
1-15. (canceled)
A method of treating fluid overload, a fluid retention or a fluid accumulation in a patient in need of a treatment with a diuretic, the method comprising:
- intravenously administering a dose of ferric carboxymaltose to the patient in need of the diuretic treatment.
A method for treating a congestion, the method comprising:
- intravenously administering a dose of ferric carboxymaltose to a patient in need thereof.
Dependencies are inferred from the claim text.